NCCN survey reveals ongoing shortages in crucial cancer medications

FHS
June 26, 2024
6:41 pm

The National Comprehensive Cancer Network (NCCN)-;a nonprofit alliance of leading cancer centers-;is publishing new results for its latest survey on cancer drug shortages in the United States.

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication

April 8, 2024

Federal judge rules against Regeneron’s attempt to halt Amgen from launching Eylea biosimilar

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 25, 2024

AstraZeneca to acquire radioconjugate biotech Fusion in $2.4bn deal – Pharmaceutical Technology

Share this article Along with Fusion’s pipeline of radioconjugates, AstraZeneca said the deal will bring new research and development (R&D) expertise and supply chain strengthening.

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.